We work Hard to get you posted with latest updates

http://We%20work%20Hard%20to%20get%20you%20posted%20with%20latest%20updates

Spend time learning about the different aspects of that topic from experts in the field.

ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody NSCLC Oncology oncology innovation oncology research Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy

Unwrap our new Directory

http://Unwrap%20our%20new%20Directory

Directory

Home
Pharma
Bio-Pharma
MedTech
Veterinary
Cosmetics
Food
.Clinical
.Tech
.edu
.gov
M&A
.VC

Nasal Polyps

Advertisement

cGxPJobs Banner

GSK Secures China Approval for Exdensur in Nasal Polyps Treatment

LONDON, UK, April 8, 2026 GSK has announced that China’s National Medical Products Administration (NMPA) has approved Exdensur (depemokimab),...

By cGxPwire Editor
April 9, 2026

Read More

.Clinical Bio-Pharma

FDA Approves TEZSPIRE for Chronic Rhinosinusitis with Nasal Polyps

THOUSAND OAKS, Calif., October 17, 2025 — In a landmark regulatory decision, the U.S. Food and Drug Administration (FDA)...

By cGxPwire Editor
October 17, 2025

Read More

Advertisement

cGxPJobs

Recent Posts

01

Bio-Pharma

Agilent Expands FDA-Approved PD-L1 Testing for KEYTRUDA Across Four Cancer Types
June 5, 2026
02

Bio-Pharma

Zenas BioPharma Reports Positive Phase 3 Obexelimab Results in IgG4-RD
June 5, 2026
03

Bio-Pharma

DBV Technologies Screens First Infant in THRIVE Peanut Allergy Study
June 5, 2026
04

.Clinical

argenx Reports Long-Term Efgartigimod Benefits in Myositis and Sjogren’s Disease at EULAR 2026
June 5, 2026
05

.Clinical

Levicept’s LEVI-04 Shows Disease-Modifying Potential in Osteoarthritis
June 5, 2026

Advertisement

Copyright © 2026 cGxP.wire | Made by 3styler

Directory

Home
Pharma
Bio-Pharma
MedTech
Veterinary
Cosmetics
Food
.Clinical
.Tech
.edu
.gov
M&A
.VC

Start typing and press Enter to search

Loading Comments...

Write a Comment...

Email (Required)

Name (Required)

Website